Fulgent Genetics (FLGT) to Post Q4 Earnings: What’s in Store? Posted byZacks Equity Research February 21, 2022 Leave a comment on Fulgent Genetics (FLGT) to Post Q4 Earnings: What’s in Store? In terms of COVID-19 NGS revenues, Fulgent Genetics (FLGT) is expected to have witnessed a rise in testing volume on increased demand through the Q4 months.